BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9458234)

  • 1. Hidden 19S IgM rheumatoid factors in Turkish patients with juvenile rheumatoid arthritis.
    Ince A; Akhter IM; Moore TL; Basaran M; Yazici Y; Ozdogan H
    J Rheumatol; 1998 Jan; 25(1):190-2. PubMed ID: 9458234
    [No Abstract]   [Full Text] [Related]  

  • 2. 7S IgG rheumatoid factor and hidden 19S IgM rheumatoid factor in juvenile chronic arthritis.
    Roizenblatt S; Goldenberg J; Gabriel A; Hilário MO; Atra E
    Allergol Immunopathol (Madr); 1993; 21(5):197-200. PubMed ID: 8160565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidden 19S IgM rheumatoid factor in synovial fluid.
    Neucks SH; Robbins DL; Moore TL; Zuckner J; Dorner RW
    J Rheumatol; 1981; 8(5):811-4. PubMed ID: 7310776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
    Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
    Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine measurement of IgM, IgG, IgA rheumatoid factors.
    Visser H; Hazes JM
    J Rheumatol; 1998 Mar; 25(3):603-4. PubMed ID: 9517791
    [No Abstract]   [Full Text] [Related]  

  • 6. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis].
    Dubrous P; Gardet V; Hugard L
    Pathol Biol (Paris); 2005 Mar; 53(2):63-7. PubMed ID: 15708648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental method and clinical significance of hidden rheumatoid factors].
    Liu S; Liu GR; Zhou Y
    Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):531-4. PubMed ID: 8269782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment.
    Bobbio-Pallavicini F; Alpini C; Caporali R; Avalle S; Bugatti S; Montecucco C
    Arthritis Res Ther; 2004; 6(3):R264-72. PubMed ID: 15142273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunofluorescence of apparently healthy skin in rheumatoid arthritis].
    Santiago MS; Fava R; Rodrigues CJ; Yoshinari NH; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(3):161-4. PubMed ID: 3074448
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].
    Youinou P; Le Goff P; Miossec P; Moineau MP; Ferec C
    Z Rheumatol; 1983; 42(1):36-9. PubMed ID: 6189305
    [No Abstract]   [Full Text] [Related]  

  • 12. Longitudinal study of the presence of hidden 19S IgM rheumatoid factor in juvenile rheumatoid arthritis.
    Moore TL; Dorner RW; Sheridan PW; Weiss TD; Baldassare AR; Osborn TG; Zuckner J
    J Rheumatol; 1982; 9(4):599-602. PubMed ID: 6215487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANA+ (anti-nuclear antibody) is correlated with RF+ (rheumatoid factor) in rheumatoid arthritis.
    Matsos MP; Pope JE; Spencer-Green G
    Inflammopharmacology; 2004; 12(3):229-31. PubMed ID: 15527547
    [No Abstract]   [Full Text] [Related]  

  • 14. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
    Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
    Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dependence of the behaviour of serum immunoglobulins on the course of the disease in progressive rheumatoid arthritis].
    Frank O; Klemmayer K
    Z Immunitatsforsch Exp Klin Immunol; 1971 Jul; 142(1):15-22. PubMed ID: 4254506
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children.
    Kasapçopur O; Ozbakir F; Arisoy N; Ingöl H; Yazici H; Ozdoğan H
    Turk J Pediatr; 1999; 41(1):67-71. PubMed ID: 10770678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rheumatoid factors: value of their determination in patients with rheumatoid arthritis].
    Ruffatti A; De Silvestro G; Meneghini P; Doria A; Pellizzaro E; Gambari PF; Todesco S
    Boll Soc Ital Biol Sper; 1983 Aug; 59(8):1160-4. PubMed ID: 6354211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A probable explanation for mild extra-articular manifestations in Indian patients of rheumatoid arthritis: a preliminary study.
    Agrawal V; Usha ; Goel SC; Gupta RM
    Indian J Pathol Microbiol; 1998 Jul; 41(3):297-301. PubMed ID: 9805851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of immunoglobulin G-containing high-molecular-weight complexes isolated from children with juvenile rheumatoid arthritis and congenital human immunodeficiency virus infection.
    Jarvis JN; Iobidze M; Taylor H; DeJonge J; Chang S
    Pediatr Res; 1993 Dec; 34(6):781-4. PubMed ID: 8108193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young age of onset is associated with increased prevalence of circulating IgM rheumatoid factor and antinuclear antibodies at presentation in women with rheumatoid arthritis.
    Jacobsen S
    Clin Rheumatol; 2004 Apr; 23(2):121-2. PubMed ID: 15045625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.